Tormere Analytics
OverviewStock ResearchChartsPortfolio LabOptions LabCalculatorsWatchlist
Data Explorer
Articles
Pricing
Privacy PolicyTerms of Service

ADRX

$19.94-3.37%⬇ financials (.py)

ADARx Pharmaceuticals, Inc.

Market Cap
—
Sector
—
Industry
—
Beta (raw)
—
Insufficient price history
P/E (TTM)
—
Price / TTM net income
P/S (TTM)
—
Price / TTM revenue
P/B
—
Price / stockholders equity
EV/EBITDA
—
TTM
Price Chart
Loading…

Signals

Insider Velocity
24.9x
buying
Congress
—
recent trades
Short Volume
54%
of daily vol

Market & Alt Data

News
11
recent articles
Activist
—
none active
Velocity Score
24.85x
Current Rate (90d)
21748.97/mo
Baseline Rate
0.00/mo
Unique Buyers (90d)
2
Sort by
Type
Trade DateFiledOwnerRoleTypeSharesPriceValueOwned After
2026-09-282026-09-30GORDON CARL LDirectorPurchase950.0K$17.00$16.15M14.33MView
2026-09-282026-09-29SR ONE CAPITAL MANAGEMENT, LLC10% OwnerPurchase1.01M$17.00$17.13M5.55MView

Recent News

At $17 a share, OrbiMed Israel Partners II buys 61,516 IPO shares in ADARx Pharmaceuticals (ADRX).
Stock Titan · 2026-09-30
Number of employees of ADARx Pharmaceuticals, Inc. – NASDAQ:ADRX
TradingView · 2026-09-28
ADARx Pharmaceuticals (ADRX) Moved Higher, But What Is Drawing Attention?
Yahoo · 2026-09-28
ARDX Stock Tumbles As Xphozah Loses Final Medicare Reimbursement Battle
Stocktwits · 2026-09-26
U.S. IPO Weekly Recap: Postponed Deals Put Damper On Fall IPO Market
SeekingAlpha · 2026-09-25
Adarx Pharmaceuticals (ADRX) Stock Analysis Report | Financials & Insights
Benzinga · 2026-09-25
Trading Halt: Halt status updated at 10:10:00 AM ET: Quotation Resumption: IPO security released for quotation
Benzinga · 2026-09-25
ADARx Pharmaceuticals Announces Pricing of Upsized $446.3 Million Initial Public Offering
Yahoo · 2026-09-24
symbol__ Stock Quote Price and Forecast
CNN · 2026-09-22
ADARx Pharmaceuticals Seeks IPO On Strong Collaboration Deal With AbbVie
SeekingAlpha · 2026-09-10
NMPA Grants ADRX-0405 IND Clearance in Late-Stage Solid/Prostate Tumors
CancerNetwork · 2026-06-09

Informational purposes only, not investment advice.

ADARx Pharmaceuticals, Inc. (ADRX)

tormere.com/research/ADRX · generated 2026-09-30

$19.94
-3.37%
General Information
Price$19.94
Change-3.37%
Market Cap—
Sector—
Industry—
Exchange—
Beta (raw, monthly vs SPY)—
Signals
Insider Velocity24.9x buying
Congress Trades—
Short Volume
54% of daily vol
Conviction Score32/100
Price Chart (1 Year)
2026-09-252026-09-30$20.64$19.35
Recent Insider Activity (Form 4) — Last 5
DateInsiderTypeSharesValue
2026-09-28GORDON CARL LP300,249$5M
2026-09-28GORDON CARL LP61,516$1M
2026-09-28GORDON CARL LP588,235$10M
2026-09-28SR ONE CAPITAL MANAGEMENT, LLCP592,593$10M
2026-09-28SR ONE CAPITAL MANAGEMENT, LLCP414,814$7M
Recent News
  • At $17 a share, OrbiMed Israel Partners II buys 61,516 IPO shares in ADARx Pharmaceuticals (ADRX). — Stock Titan · 2026-09-30
  • Number of employees of ADARx Pharmaceuticals, Inc. – NASDAQ:ADRX — TradingView · 2026-09-28
  • ADARx Pharmaceuticals (ADRX) Moved Higher, But What Is Drawing Attention? — Yahoo · 2026-09-28
  • ARDX Stock Tumbles As Xphozah Loses Final Medicare Reimbursement Battle — Stocktwits · 2026-09-26
  • U.S. IPO Weekly Recap: Postponed Deals Put Damper On Fall IPO Market — SeekingAlpha · 2026-09-25

Tormere — informational purposes only, not investment advice.

Factor Profile

Pro
Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro →